intends to use the net proceeds from the offering to finance, in part, its pending acquisitions of Clariant AG's global masterbatch business (the "Clariant masterbatch acquisition") and Clariant Chemicals (India) Limited's masterbatch business (collectively, the "acquisitions"). The notes will be subject to a "special mandatory redemption" in the event that (i) the Clariant masterbatch acquisition is not consummated on or prior to the purchase agreement is terminated, other than in connection with the consummation of the Clariant masterbatch acquisition.

intends to use the net proceeds from the offering to finance, in part, its pending acquisitions of Clariant AG's global masterbatch business (the "Clariant masterbatch acquisition") and Clariant Chemicals (India) Limited's masterbatch business (collectively, the "acquisitions"). The notes will be subject to a "special mandatory redemption" in the event that (i) the Clariant masterbatch acquisition is not consummated on or prior to the purchase agreement is terminated, other than in connection with the consummation of the Clariant masterbatch acquisition.

Requirements: Skin contact colorant certified for ISO 10993 biocompatibility Solution: OnColor™ HC Plus, MEVOPUR® 5. Requirements: Dark mark for rapid labeling Solution: OnCap™ Fast Mark™ Laser Marking Additives, MEVOPUR® 6. Requirements: USP Class VI skin contact colorant for drug differentiation Solution: OnColor™ HC, MEVOPUR® 4 Button 5 Batch or SKU identifier Safety and trigger cap 6 DRUG CONCENTRATION 1 DRUG CONCENTRATION 2 DRUG CONCENTRATION 3 Patient Handling Age or certain disease states can severely limit patient dexterity making the self-administration of medication difficult and frustrating.

If the material is allowed to stay in an injection molding machine or extruder (profile, sheet, etc.) too long, the material will start to discolor and brown ‘freckles’ may appear.  Get the answers to these questions by downloading our PDF Guide to Polyketone overview brochure. Download PDF

Unless otherwise noted herein, all comparisons to prior year results are pro forma for the Clariant Masterbatch acquisition. The company said it is ahead of schedule in capturing cost synergies from the Clariant Masterbatch acquisition and now expects to achieve $45 million in the current year from the previously announced $35 million. Pro Forma The Company acquired the Clariant Masterbatch business (“CMB”) on July 1, 2020 (the “Acquisition Date”).

We are better together through: Keeping Safety First — PolyOne and Clariant are both ACC Responsible Care® companies, and nothing is more important than the health, safety and well-being of our people. D is t. ) K W R P P G F U L R P M A V Y F M C H U N H X L S C L E C L E M N C E A S H Source: Peer data per Bloomberg market data as of February 15, 2022. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $635M and estimated CAPEX of $90M (excludes IT system upgrade of $25M and synergy capture CAPEX of $20M) Source: Peer data per Bloomberg market data as of February 15, 2022 86 89 85 80 76 76 89 85 79 78 76 76 76 70 69 63 8 A vi e nt K W R P P G F U L A V Y R P M F M C U N V R H U N B N R H X L E C L C E A S H E M N S C L A LB Source: Peer data per Bloomberg market data as of February 15, 2022 Total Enterprise Value / 2022E EBITDAWith the Clariant Color business acquisition and divestment of the PP&S business, our exposure is now concentrated in less-cyclical and high-growth markets.

Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”). D is t. ) K W R P P G A V Y F U L R P M G C P F M C H X L H U N E C L E M N C E A S H S C L Source: Peer data per Bloomberg market data as of December 2, 2021 Avient reflects 2021 estimated revenue of $4,750M and estimated CAPEX of $80M (excludes one-time synergy capture CAPEX of $20M) 129Avient Corporation 474 644 1,002 107 147 216 467 616 872 2014 2018 2021E R&D / Technical Marketing Sales Commercial Resources Headcount figures all Pro Forma for sale of Designed Structures and Solutions (DSS) and Performance Products and Solutions (PP&S) segments. 2021E data as of October 31, 2021. Peer data per Bloomberg market data as of December 2, 2021.

Pro Forma Financial Information Avient acquired the Clariant Color business on July 1, 2020 (the “Acquisition Date”). To provide comparable financial results, Avient references “pro forma” financial metrics, which include the business results of Clariant Color for periods prior to the Acquisition Date. AVIENT: WHO WE ARE 38 21 9 34 • U.S. and Canada • Latin America • Europe, Middle East & Africa • Asia 25,000+ CUSTOMERS Headquartered in Avon Lake, OH (Cleveland) 8,800+ employees 100+ manufacturing plants Key Financial Data 2022E Sales $5.1 billion 2022E EBITDA $635 million 2022E EPS $3.50 >70% ARE CUSTOMIZED SOLUTIONS TO UNIQUE SPECIFICATIONS of sales 3 WHO WE ARE – VISION, STRATEGY, CULTURE 4 Avient Corporation (NYSE: AVNT) provides specialized and sustainable material solutions that transform customer challenges into opportunities, bringing new products to life for a better world.

D is t. ) R P M P P G K W R F U L A V Y G C P IF F F M C H X L H U N E M N F O E E C L K R A S C L A S H C E G R A A LB Median: 5%Median: 3% Source: Peer data per Bloomberg market data as of February 5, 2021 Avient reflects 2021 estimated revenue of $4,100M and excludes one-time synergy capture CAPEX ($20M) Avient Specialty Formulators Other Chemical/Specialty Companies Free Cash Flow Conversion (1) 2021E (%) Being asset light helps us to generate strong free cash flow that is in line with specialty formulators. Free cash flow conversion calculated as (EBITDA – Capex) / EBITDA Median: 83% Median: 76% HIGH FREE CASH FLOW CONVERSION Avient reflects 2021 estimated EBITDA of $510M and excludes one-time synergy capture CAPEX ($20M) Source: Peer data per Bloomberg market data as of February 5, 2021 85 87 86 86 81 81 59 92 88 81 79 79 79 76 76 75 73 67 67 64 60 7 A vi en t P P G K W R R P M F U L A V Y G C P IF F F M C U N V R H X L E M N B N R E C L C E A S H F O E G R A H U N K R A S C L A L B Source: Peer data per Bloomberg market data as of February 5, 2021 Total Enterprise Value / 2021E EBITDA Our current valuation implies an EBITDA multiple that is significantly below specialty formulator peers and our historic valuations, when the company had considerable exposure to more cyclical and challenging end markets. Avient acquired the Clariant Masterbatch business (CMB) on July 1, 2020 (the “Acquisition Date”).

Executive Vice President and CFO, will provide insights and commentary on the company's growth expectations for the first quarter, strong financial position, as well as the status of the previously announced Clariant Masterbatch acquisition.  In these globally challenging times, our priority remains on the health and safety of our associates, customers and communities," said As such, and given recent inbound investor inquiries regarding current market conditions and the Clariant transaction, we are going to host this call Friday to discuss these topics.